“Article: Updated results of the phase III COLUMBUS trial further solidify BRAF/MEK combinations as standard of care for BRAF-mutated advanced melanoma” has been added to your cart. View cart
Article: O.6 Successful Transition from paediatric to adult care in Sickle Cell Disease: An Experience in a Belgian Center